Investors & Media

SEC Filings

Document Details

Form
Filing Date
July 23, 2019
Document Date
July 19, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Svennilson Peter

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com